Regression of left ventricular hypertrophy in children with antihypertensive therapy.
Left ventricular hypertrophy (LVH) is a complication of hypertension that has received great attention in the adult population. Large-scale randomized control studies in adults have demonstrated that LVH regresses in response to pharmacologic intervention. While it is known that LVH occurs as a complication of hypertension in the pediatric population, few studies have focused on its regression with pharmacological intervention. We report on three cases of hypertension-induced LVH in the pediatric population and its regression after treatment with antihypertensive medications. This report brings to light the need for larger, prospective studies on the incidence, natural history, and treatment of LVH associated with hypertension in the pediatric population.
Ramaswamy
Prema
P
Division of Pediatric Cardiology, Maimonides Infants and Children's Hospital, 977 48th Street, Brooklyn, NY 11219, USA. pramaswamy@maimonidesmed.org
Lytrivi
Irene D
ID
Paul
Chikku
C
Golden
Mary
M
Kupferman
Juan C
JC
D000293:Adolescent; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002648:Child; D018450:Disease Progression; D004656:Enalapril / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications*; D017379:Hypertrophy, Left Ventricular / Q000188:drug therapy* / Q000209:etiology*; D008297:Male; D012074:Remission Induction
D000959:Antihypertensive Agents; D004656:Enalapril